Overall rank by patents
#25,068
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
According to USPTO PatentsView, Realta ranks #25,068 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R25068 · US Corporation #25,068 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Rajant Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Realta Holdings · this assignee
27 score
3D Lighting Innovati… · lowest
7 score
What this shows Realta's Innovation Score is 26.9/100 (top 78% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Realta Holdings, Llc is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2018. By volume, Realta sits between Rajant Corporation and Repro-med Systems, Inc..
Realta Holdings, Llc shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
RAJANT CORPORATION
11 patents
RAM Photonics Industrial, LLC
11 patents
RANDAEMON sp. z o.o
11 patents
RAPA Automotive GmbH & Co. KG
11 patents
REM Technology Inc.
11 patents
REMACRO TECHNOLOGY CO., LTD.
11 patents
REMD Biotherapeutics, Inc.
11 patents
REPRO-MED SYSTEMS, INC.
11 patents
REALTA HOLDINGS, LLC
11 patents
What this shows Realta holds 11 patents at rank #25,046, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #25,046 in granted patent volume.
Other assignees with the most granted patents in Realta's primary technology class.
Realta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 Top 78% higher than 22% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2020 | 1 | 9.1% |
| 2021 | 4 | 36.4% |
| 2023 | 2 | 18.2% |
| 2025partial year | 2 | 18.2% |
Top 4 of 4 technology areas
Overall rank by patents
#25,068
of 50,000 tracked assignees
26.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.